Hepa Wash Initiates Collaboration with German Accelerator Life Sciences to Prepare U.S. Expansion

Hepa Wash, a Munich-based manufacturer of the worldwide first method for advanced multi-organ support, announced today its collaboration with the German Accelerator Life Sciences (GALS) program, an initiative founded by the German Federal Ministry for Economic Affairs and Energy (BMWi), to facilitate the company’s U.S. expansion.

Berlin-based Ada Health Raises $47M

Ada Health has raised a $47M (€40M) funding round led by Access Industries, Len Blavatnik’s global investment group. Joining the round in the Berlin-HQ’d startup was June Fund and Berlin-based Cumberland VC. William Tunstall-Pedoe, the AI entrepreneur who came up with the Siri-like “Evi” app which was then acquired by Amazon and incorporated into what became Alexa, also participated in this round, as did existing investors.

Berlin’s Ada Health raises $47M to become the Alexa of healthcare

AYOXXA introduces LUNARIS™, its advanced fully integrated low-volume beads-on-a-chip multiplex protein analysis system

AYOXXA Biosystems GmbH, an international biotechnology company, today announces the introduction of its advanced low-volume beads-on-a-chip multiplex protein analysis system. The LUNARIS™ system can be readily integrated into any laboratory routine and is optimized to provide easy-to-use, standardized workflow from sample to result.

http://www.ayoxxa.com/newsroom/ayoxxa-introduces-lunaris/

Adhesys Medical acquired by Grünenthal Group

The Grünenthal Group today announced the acquisition of the company Adhesys Medical to expand its pipeline of medical devices for its business with surgeons

The acquisition of Adhesys Medical and its highly innovative pipeline of surgical sealants, together with the underlying technology platform, allows Grünenthal to tap into the global $1 billion surgical sealants market

First Four Companies Selected to Participate in the German Accelerator Life Sciences Program in Cambridge

During the 34th JP Morgan Healthcare Conference, the German Accelerator Life Sciences (GALS) announced the first four companies to participate in its Cambridge-based program. AYOXXA Biosystems, PEPperPRINT, Personal MedSystems, and Sonormed will receive support tailored towards the specific needs of each company.

Rigontec Raises Additional €15M in Extended Series A to Advance Novel RIG-I Targeted Immuno-Oncology Therapeutics

Rigontec announced that it secured EUR 15 million in a third and final closing of its Series A round. The funding will advance the ongoing development of Rigontec’s RIG-I agonist platform targeting oncological, anti-infective and inflammatory indications as well as accelerate the progress of lead candidate RGT100 towards the clinic.

Press Release: Adhesys Medical Announces Collaboration with GALS

Adhesys Medical, a medical device company developing the next generation of surgical adhesives, announced today its acceptance into the German Accelerator Life Sciences (GALS) program.

Adhesys Medical, a medical device company developing the next generation of surgical adhesives, announced today its acceptance into the German Accelerator Life Sciences (GALS) program.